Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 3/20 | 0.39 |
| ▸ | MGLL | Q99685 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | PDE6D | O43924 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | HTR7 | P34969 | 1/20 | 0.31 |
| ▸ | COMT | P21964 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16017498 | 0.92 | ALDH1A1 (0.47) | FAAHMGLLALDH1A1HSP90AA1PKM | |
| SCHEMBL20022909 | 0.92 | FAAH (0.35) | FAAHMGLLALDH1A1HSP90AA1PKM | |
| SCHEMBL20022912 | 0.91 | ALDH1A1 (0.44) | FAAHMGLLALDH1A1HSP90AA1PKM | |
| SCHEMBL20022914 | 0.90 | ALDH1A1 (0.45) | FAAHMGLLALDH1A1HSP90AA1PKM | |
| SCHEMBL20022917 | 0.89 | ALDH1A1 (0.44) | FAAHMGLLALDH1A1HSP90AA1PKM | |
| SCHEMBL20383373 | 0.89 | MGLL (0.38) | FAAHMGLLALDH1A1PDE6D | |
| SCHEMBL20022913 | 0.88 | PDE6D (0.39) | FAAHMGLLALDH1A1HSP90AA1PKM | |
| SCHEMBL20022897 | 0.88 | MGLL (0.42) | FAAHMGLLALDH1A1HSP90AA1PKM | |
| SCHEMBL20022900 | 0.87 | FAAH (0.34) | FAAHMGLLALDH1A1HSP90AA1PKM | |
| SCHEMBL17943516 | 0.86 | FAAH (0.40) | FAAHMGLLALDH1A1HSP90AA1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180097181-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-04-05 | — | — | US | disclosed |
| US-20180097181-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180097181-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | PKD1, PIEZO1, ETV6 | FAAH 2834/4885MGLL 3711/4885ALDH1A1 525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.